MENA Biologics & Biosimilars Market- Regional Analysis
Among region, the Gulf region is estimated to hold a dominant position in the MENA biologics & biosimilars market over the forecast period owing to increasing government initiatives for vaccination campaigns that boosts thesegment growth. For instance, on October 16, 2020, the Ministry of Health (Kuwait) launched a seasonal vaccination campaign for infectious diseases such as seasonal influenza and pneumococcal pneumonia.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients